JB Chemicals and Pharmaceuticals has proposed a final dividend of Rs. 9.3 per share for the fiscal year 2025-26, subject to shareholder approval at the Annual General Meeting. If approved, the dividend will be distributed within a month following the meeting.

JB Chemicals reported a 33% drop in Q4 net profit compared to last year, with earnings dropping from ₹1.5 billion to ₹1.01 billion. Additionally, quarterly revenue slipped slightly to ₹9.04 billion from ₹9.5 billion.

Despite a 30.4% year-on-year drop in Q4 net profit and a 4.8% decline in revenue, JB Chemicals' shares still rose by 2.9%, closing at ₹2,215 on the BSE, potentially suggesting investor optimism about the company's future prospects despite current business challenges in revenue, EBITDA, and international operations.

JB Chemicals executed a significant block trade on the National Stock Exchange (NSE), valued at approximately INR 31.3 crore, with each share trading at around INR 2006.7.